IOIOF yields 3.58% · JNJ yields 2.13%● Live data
📍 IOIOF pulled ahead of the other in Year 1
Combined, IOIOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IOIOF + JNJ for your $10,000?
IOI Corporation Berhad, an investment holding company, engages in the plantation business in Malaysia, Europe, North America, Asia, and internationally. The company operates through two segments, Plantation and Resource-Based Manufacturing. It cultivates oil palm, softwood timber, and rubber; refines and processes crude palm and palm kernel oils; and manufactures specialty oils and fats. The company also manufactures and exports fatty acids, soap noodles, glycerine, fatty esters, and other related products. In addition, it is involved in the commercialization of clonal ramets and biotechnology related research and development activities; provision of management and marketing services; production and supply of palm-based renewable energy; and trading of palm oil commodities. Further, the company engages in the property development, maintenance, and investment activities; issuance of exchangeable bonds and guaranteed notes; storage tanks rental activities; manufacture, registration, trading, and distribution of oleochemical products; and provision of bulk cargo warehousing services, as well as treasury management services and management consulting services. It owns oil palm planted area of 176,980 hectares. The company was formerly known as Industrial Oxygen Incorporated Sdn Bhd and changed its name to IOI Corporation Berhad in March 1995. IOI Corporation Berhad was incorporated in 1969 and is based in Putrajaya, Malaysia.
Full IOIOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.